Tear Film Evaluation After Phacoemulsification
TFAP
To Investigate Tear Film Change After Phacoemulsification With SS-OCT
1 other identifier
observational
60
1 country
1
Brief Summary
To compare tear film differences between surgical eyes and nonsurgical eyes in patients who had cataract surgery by phacoemulsification in one eye.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 28, 2014
CompletedFirst Posted
Study publicly available on registry
September 12, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedSeptember 12, 2014
September 1, 2014
7 months
August 28, 2014
September 11, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phacoemulsification influence on the postoperative tear functions
1 year
Study Arms (2)
surgery group
patients underwent cataract surgery with 3.0 mm clear corneal incision at 11 o'clock in one eye
control group
patients' other eye that did not have surgery
Interventions
All patients underwent cataract surgery with 3.0 mm clear corneal incision at 11 o'clock in one eye
Eligibility Criteria
60 eyes from 30 age-related cataract participants underwent cataract surgery with 3.0 mm clear corneal incision at 11 o'clock in one eye and the other eye without surgery history
You may qualify if:
- age-related cataract without surgery history and dry eye symptoms history
You may not qualify if:
- diseases influencing tear secretion (such as Sjögren syndrome, Steve-Johnson syndrome, diabetes, thyroid disease, etc.); history of ocular surgeries or nuclear hardness IV and V, which required the use of larger phacoemulsification energy; use of drugs that affect tear secretion and stability (such as glaucoma medications, artificial tears, corticosteroid drugs, etc.); or presence of ocular diseases (such as Pterygium, blepharitis, uveitis, glaucoma, lacrimal apparatus, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zheng Qianlead
Study Sites (1)
Wenzhou Medical University
Wenzhou, Zhejiang, 325027, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qian Zheng, MD
Wenzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Wenzhou Medical University
Study Record Dates
First Submitted
August 28, 2014
First Posted
September 12, 2014
Study Start
October 1, 2013
Primary Completion
May 1, 2014
Study Completion
March 1, 2015
Last Updated
September 12, 2014
Record last verified: 2014-09